Moore Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,000	Closed	-$792K	–	872
2021 Q1	$792K	Sell	25,000 -25,000	-50%	-$1.04M	0.02%	523
2020 Q4	$2.32M	Sell	50,000 -169,982	-77%	-$6.75M	0.04%	342
2020 Q3	$7.24M	Buy	219,982 +169,982	+340%	+$5.21M	0.19%	141
2020 Q2	$1.37M	Buy	50,000 +25,000	+100%	+$822K	0.04%	202
2020 Q1	$748K	Sell	25,000 -111,040	-82%	-$2.94M	0.04%	138
2019 Q4	$3.77M	Buy	136,040 +12,441	+10%	+$283K	0.14%	158
2019 Q3	$2.25M	Buy	123,599 +48,599	+65%	+$1.07M	0.11%	204
2019 Q2	$1.84M	Sell	75,000 -75,000	-50%	-$1.13M	0.06%	233
2019 Q1	$1.43M	Hold	150,000	–	–	0.05%	218
2018 Q4	$1.33M	Buy	150,000 +25,000	+20%	+$241K	0.07%	166
2018 Q3	$1.41M	Buy	125,000 +75,000	+150%	+$1.06M	0.05%	206
2018 Q2	$640K	Buy	+50,000	New	+$731K	0.02%	225